Alexander Cervone

Comparative Safety and Effectiveness of Warfarin or Rivaroxaban Versus Apixaban in Patients With Advanced CKD and Atrial Fibrillation: Nationwide US Cohort Study

Edouard L. Fu, Rishi Desai, Julie M. Paik et al. · American Journal of Kidney Diseases · 2023 · 30 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Comparative Effectiveness and Safety of Oral Anticoagulants by Dementia Status in Older Patients With Atrial Fibrillation

Kueiyu Joshua Lin, Daniel E. Singer, Katsiaryna Bykov et al. · JAMA Network Open · 2023 · 22 citations · Full text

Medicine, Cardiology, Geriatric Medicine +11

A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetes

Edouard L. Fu, Julianna Mastrorilli, Katsiaryna Bykov et al. · Kidney International · 2023 · 19 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation

Tracey G. Simon, Daniel E. Singer, Yichi Zhang et al. · Annals of Internal Medicine · 2024 · 19 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Frailty, Home Time, and Health Care Costs in Older Adults With Atrial Fibrillation Receiving Oral Anticoagulants

Kueiyu Joshua Lin, Daniel E. Singer, Darae Ko et al. · JAMA Network Open · 2023 · 12 citations · Full text

Medicine, Geriatric Medicine, Pharmacoeconomics +17